23
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      TOR complex 2 localises to the cytokinetic actomyosin ring and controls the fidelity of cytokinesis

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          ABSTRACT

          The timing of cell division is controlled by the coupled regulation of growth and division. The target of rapamycin (TOR) signalling network synchronises these processes with the environmental setting. Here, we describe a novel interaction of the fission yeast TOR complex 2 (TORC2) with the cytokinetic actomyosin ring (CAR), and a novel role for TORC2 in regulating the timing and fidelity of cytokinesis. Disruption of TORC2 or its localisation results in defects in CAR morphology and constriction. We provide evidence that the myosin II protein Myp2 and the myosin V protein Myo51 play roles in recruiting TORC2 to the CAR. We show that Myp2 and TORC2 are co-dependent upon each other for their normal localisation to the cytokinetic machinery. We go on to show that TORC2-dependent phosphorylation of actin-capping protein 1 (Acp1, a known regulator of cytokinesis) controls CAR stability, modulates Acp1–Acp2 (the equivalent of the mammalian CAPZA–CAPZB) heterodimer formation and is essential for survival upon stress. Thus, TORC2 localisation to the CAR, and TORC2-dependent Acp1 phosphorylation contributes to timely control and the fidelity of cytokinesis and cell division.

          Abstract

          Highlighted Article: A role for the TOR signalling pathway in regulating cytokinesis is identified. This myosin-dependent mechanism modulates the stability of the S. pombe CapZ complex to regulate actin function.

          Related collections

          Most cited references38

          • Record: found
          • Abstract: found
          • Article: not found

          Nuclear size control in fission yeast

          Along-standing biological question is how a eukaryotic cell controls the size of its nucleus. We report here that in fission yeast, nuclear size is proportional to cell size over a 35-fold range, and use mutants to show that a 16-fold change in nuclear DNA content does not influence the relative size of the nucleus. Multi-nucleated cells with unevenly distributed nuclei reveal that nuclei surrounded by a greater volume of cytoplasm grow more rapidly. During interphase of the cell cycle nuclear growth is proportional to cell growth, and during mitosis there is a rapid expansion of the nuclear envelope. When the nuclear/cell (N/C) volume ratio is increased by centrifugation or genetic manipulation, nuclear growth is arrested while the cell continues to grow; in contrast, low N/C ratios are rapidly corrected by nuclear growth. We propose that there is a general cellular control linking nuclear growth to cell size.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Profilin regulates F-actin network homeostasis by favoring formin over Arp2/3 complex.

            Fission yeast cells use Arp2/3 complex and formin to assemble diverse filamentous actin (F-actin) networks within a common cytoplasm for endocytosis, division, and polarization. Although these homeostatic F-actin networks are usually investigated separately, competition for a limited pool of actin monomers (G-actin) helps to regulate their size and density. However, the mechanism by which G-actin is correctly distributed between rival F-actin networks is not clear. Using a combination of cell biological approaches and in vitro reconstitution of competition between actin assembly factors, we found that the small G-actin binding protein profilin directly inhibits Arp2/3 complex-mediated actin assembly. Profilin is therefore required for formin to compete effectively with excess Arp2/3 complex for limited G-actin and to assemble F-actin for contractile ring formation in dividing cells.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Homeostatic actin cytoskeleton networks are regulated by assembly factor competition for monomers.

              Controlling the quantity and size of organelles through competition for a limited supply of components is quickly emerging as an important cellular regulatory mechanism. Cells assemble diverse actin filament (F-actin) networks for fundamental processes including division, motility, and polarization. F-actin polymerization is tightly regulated by activation of assembly factors such as the Arp2/3 complex and formins at specific times and places. We directly tested an additional hypothesis that diverse F-actin networks are in homeostasis, whereby competition for actin monomers (G-actin) is critical for regulating F-actin network size. Here we show that inhibition of Arp2/3 complex in the fission yeast Schizosaccharomyces pombe not only depletes Arp2/3-complex-mediated endocytic actin patches, but also induces a dramatic excess of formin-assembled F-actin. Conversely, disruption of formin increases the density of Arp2/3-complex-mediated patches. Furthermore, modification of actin levels significantly perturbs the fission yeast actin cytoskeleton. Increasing actin favors Arp2/3-complex-mediated actin assembly, whereas decreasing actin favors formin-mediated contractile rings. Therefore, the specific actin concentration in a cell is critical, and competition for G-actin helps regulate the proper amount of F-actin assembly for diverse processes.
                Bookmark

                Author and article information

                Journal
                J Cell Sci
                J. Cell. Sci
                JCS
                joces
                Journal of Cell Science
                The Company of Biologists Ltd
                0021-9533
                1477-9137
                1 July 2016
                1 July 2016
                : 129
                : 13
                : 2613-2624
                Affiliations
                [1 ]School of Biosciences, University of Kent , Giles Lane, Canterbury, Kent CT2 7NJ, UK
                [2 ]Faculty of Life Sciences, University of Manchester , Oxford Road, Manchester M13 9PT, UK
                [3 ]Proteome Center Tübingen , Auf der Morgenstelle 15, Tübingen 72076, Germany
                [4 ]Flinders Centre for Innovation in Cancer, School of Medicine, Flinders University , Adelaide, SA 5001, Australia
                [5 ]South Australia Health and Medical Research Institute , North Terrace, PO Box 11060, Adelaide, SA 5000, Australia
                Author notes
                [*]

                These authors contributed equally to this work

                Author information
                http://orcid.org/0000-0003-2502-5274
                Article
                JCS190124
                10.1242/jcs.190124
                4958305
                27206859
                abcd61a8-6114-423d-9ba0-a66ceed90cb2
                © 2016. Published by The Company of Biologists Ltd

                This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution and reproduction in any medium provided that the original work is properly attributed.

                History
                : 30 March 2016
                : 6 May 2016
                Funding
                Funded by: University of Kent, http://dx.doi.org/10.13039/501100001316;
                Funded by: University of Manchester, http://dx.doi.org/10.13039/501100000770;
                Funded by: University of Flinders;
                Funded by: Biotechnology and Biological Sciences Research Council, http://dx.doi.org/10.13039/501100000268;
                Award ID: BB/J012793/1
                Funded by: Royal Society, http://dx.doi.org/10.13039/501100000288;
                Funded by: Cairn Research Ltd;
                Funded by: Wellcome Trust, http://dx.doi.org/10.13039/100004440;
                Funded by: Cancer Research UK, http://dx.doi.org/10.13039/501100000289;
                Award ID: C10888/A11178
                Categories
                Research Article

                Cell biology
                rictor,tor,torc2,myosin ii,myosin v,acp1,capza,schizosaccharomyces pombe
                Cell biology
                rictor, tor, torc2, myosin ii, myosin v, acp1, capza, schizosaccharomyces pombe

                Comments

                Comment on this article